Located on chromosome 1q23.3, discoidin domain receptor 2 (DDR2) is a member of the receptor tyrosine kinase (RTK) family [14,15,16], and has been closely associated with the progression of various cancers, including breast and prostate cancer [17,18,19]. This evidence concerns the gene DDR2 and prostate carcinoma.